MedPath
FDA Product

Oxaprozin

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Oxaprozin

71335-0902

Regulatory Information

71335-0902

ANDA075845

C73584

May 23, 2023

USA

These highlights do not include all the information needed to use OXAPROZIN TABLETS safely and effectively. See full prescribing information for OXAPROZIN TABLETS. OXAPROZIN tablets, for oral use Initial U.S. Approval: 1992

HUMAN PRESCRIPTION DRUG LABEL

5

Company Information

171714327

Active Ingredients

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

METHYLCELLULOSE (100 MPA.S)

Code: 4GFU244C4J

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

POLACRILIN POTASSIUM

Code: 0BZ5A00FQU

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

POLYSORBATE 80

Code: 6OZP39ZG8H

Class Code: IACT

STARCH, CORN

Code: O8232NY3SJ

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

OXAPROZIN

Quantity: 600 mg in 1 1

Code: MHJ80W9LRB

Class Code: ACTIB

Active Moieties

OXAPROZIN

Code: MHJ80W9LRB

© Copyright 2025. All Rights Reserved by MedPath